EMPLOYEE LOGIN
  • Facebook
  • Twitter
  • Instagram
  • RSS
  • Facebook
  • Twitter
  • Instagram
  • RSS
  • Corporate and Investor Info
    • Who We Are
    • Quality
    • Board of Directors
    • Our Senior Team
    • News
    • Upcoming Events
    • Financial Reports
    • Stock Info
    • Presentations
    • Analyst Coverage
    • Corporate Governance
  • For IVD Manufacturers
    • View All Antigens (Raw Materials)
    • Childhood Disease Antigens
    • Dengue Antigens
    • Gastrointestinal and Other Antigens
    • STI Antigens
    • ToRCH Antigens
  • Controls (QAPs™)
    • View All QAPs™
    • COVID-19 Products
    • PROCEEDx™ (RUO)
    • ONBOARDx™ Kits (RUO)
    • PTDx™ Proficiency Testing
    • REDx™ Controls
    • Distributors
  • BLOG
0 Items
Microbix Biosystems Inc.
  • Corporate and Investor Info
    • Who We Are
    • Quality
    • Board of Directors
    • Our Senior Team
    • News
    • Upcoming Events
    • Financial Reports
    • Stock Info
    • Presentations
    • Analyst Coverage
    • Corporate Governance
  • For IVD Manufacturers
    • View All Antigens (Raw Materials)
    • Childhood Disease Antigens
    • Dengue Antigens
    • Gastrointestinal and Other Antigens
    • STI Antigens
    • ToRCH Antigens
  • Controls (QAPs™)
    • View All QAPs™
    • COVID-19 Products
    • PROCEEDx™ (RUO)
    • ONBOARDx™ Kits (RUO)
    • PTDx™ Proficiency Testing
    • REDx™ Controls
    • Distributors
  • BLOG
Select Page

Post Categories

  • Corporate & Investor Info
  • COVID-19 Blog
  • News
  • Presentation
  • Product News
  • Uncategorized
  • Upcoming Events

ONBOARDx™FLOQ® SARS-CoV-2 Variant Swab Kit / Verification Panel 20% off!

By Pavel Zhelev | March 31, 2021

Microbix Announces Annual and Special Meeting Voting Results

By Pavel Zhelev | March 31, 2021

Virtual AGM on March 30, 2021

By Pavel Zhelev | March 30, 2021

AGM Presentation – March 2021

By Pavel Zhelev | March 29, 2021

Microbix & Seegene Canada Form COVID-Variant Collaboration

By Pavel Zhelev | March 15, 2021

Microbix Antigen-test QAPs Now Available For Clinical Use

By Pavel Zhelev | March 11, 2021

Microbix Announces Issuance of Stock Options

By Pavel Zhelev | February 18, 2021

Microbix Announces Quality Products Distribution Agreement

By Pavel Zhelev | February 16, 2021

Microbix Reports Results for Q1 Fiscal 2021

By Pavel Zhelev | February 11, 2021

Microbix Announces Material First Sales of Viral Transport Medium

By Pavel Zhelev | February 9, 2021

Microbix Viral Transport Medium Now Available

By Pavel Zhelev | January 28, 2021

Microbix & Copan Italia Execute Strategic Agreement

By Pavel Zhelev | December 21, 2020

Microbix Reports Results for Fiscal 2020

By Pavel Zhelev | December 18, 2020

Microbix Presenting Product Results at AACC

By Pavel Zhelev | December 15, 2020

Microbix Announces Addition to Board of Directors

By Pavel Zhelev | December 7, 2020

INVESTORS

  • News Releases
  • Upcoming Events
  • Financial Reports
  • Stock Info
  • Fact Sheet
  • Presentations
  • Corporate Governance
  • Contact
  • Careers

PARTNERING

  • Opportunities

Legal

  • Financial Reports
  • Terms & Conditions
  • Accessibility Policy
  • Privacy Statement
© 2021 Microbix Biosystems
  • Corporate and Investor Info
  • For IVD Manufacturers
  • Controls (QAPs™)
  • BLOG
  • Facebook
  • Twitter
  • Instagram
  • RSS

Designed by Elegant Themes | Powered by WordPress